ATRC (AtriCure) GF Value : $46.88 (As of Jun. 24, 2025)

View and export this data going back to 2005. Start your Free Trial

What is AtriCure GF Value?

As of today (2025-06-24), AtriCure's share price is $31.90. AtriCure's GF Value is $46.88. Therefore, AtriCure's Price-to-GF-Value for today is 0.68. Based on the relationship between the current stock price and the GF Value, GuruFocus believes AtriCure is Significantly Undervalued.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

AtriCure (NAS:ATRC) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (1)
Possible Value Trap, Think Twice	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (2)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (2)	Predictable High Quality Companies which are Significantly Undervalued

(1) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(2) A sufficient margin of safety exists only when the stock is undervalued.

Possible Value Trap, Think Twice companies are those that appear significantly undervalued based on their Price-to-GF-Value ratio, but whose fundamentals show signs of weakness.

Indicators that a company may be a value trap include:

    * Deteriorating Financial Health: A low Altman Z-scores indicates a higher risk of bankruptcy, or a low Piotroski F-Score.
    * Earnings Manipulation: A high Beneish M-score indicates potential earnings manipulation, raising concerns about the reliability of reported financials.
    * Stagnant or Declining Growth: Lack of revenue or earnings growth, or a recent slowdown, may signal limited future prospects.

Investors should conduct thorough due diligence, examining financial statements and growth indicators, to avoid falling into value traps.

AtriCure's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	31.90	/	46.88
	=	0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AtriCure GF Value Related Terms

Thank you for viewing the detailed overview of AtriCure's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

AtriCure Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AtriCure Inc (NAS:ATRC) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

7555 Innovation Way, Mason, OH, USA, 45040

Website

https://www.atricure.com

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Executives

Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Maggie Yuen	director	ONE PENUMBRA PLACE, ALAMEDA CA 94502
Salvatore Privitera	officer: VP; Product Development	7555 INNOVATION WAY, MASON OH 45040
Justin J Noznesky	officer: SVP, Mktg & Business Develop	7555 INNOVATION WAY, MASON OH 45040
Karl S. Dahlquist	officer: Chief Legal Officer	7555 INNOVATION WAY, MASON OH 45040
Vinayak Doraiswamy	officer: Chief Scientific Officer	7555 INNOVATION WAY, MASON OH 45040
Deborah Lee Yount	officer: Chief Human Resources Officer	7555 INNOVATION WAY, MASON OH 45040
Tonya Austin	officer: Chief Human Resources Officer	7555 INNOVATION WAY, MASON OH 45040
Mark A Collar	director	382 BISHOPBRIDGE DR, CINCINNATI OH 45255
Angela L Wirick	officer: Chief Financial Officer	7555 INNOVATION WAY, MASON OH 45040
Regina E Groves	director	5751 COPLEY DRIVE, SAN DIEGO CA 92111
Douglas J Seith	officer: SVP of Sales and Marketing	7555 INNOVATION WAY, MASON OH 45040
Deborah H Telman	director	2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Scott William Drake	director	9965 FEDERAL DRIVE, COLORADO SPRINGS CO 80921
Sven Wehrwein	director